WO2001063293A8 - Proteines et genes et leur utilisation dans le diagnostic et le traitement de la schizophrenie - Google Patents
Proteines et genes et leur utilisation dans le diagnostic et le traitement de la schizophrenieInfo
- Publication number
- WO2001063293A8 WO2001063293A8 PCT/GB2001/000783 GB0100783W WO0163293A8 WO 2001063293 A8 WO2001063293 A8 WO 2001063293A8 GB 0100783 W GB0100783 W GB 0100783W WO 0163293 A8 WO0163293 A8 WO 0163293A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- schizophrenia
- spis
- treatment
- diagnosis
- detectable
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/30—Psychoses; Psychiatry
- G01N2800/302—Schizophrenia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychiatry (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cell Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2001233954A AU2001233954A1 (en) | 2000-02-24 | 2001-02-23 | Proteins, genes and their use for diagnosis and treatment of schizophrenia |
EP01905991A EP1259818A2 (fr) | 2000-02-24 | 2001-02-23 | Diagnostic et traitement de la schizophrenie |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0004415A GB0004415D0 (en) | 2000-02-24 | 2000-02-24 | Proteins and their use for diagnosis and treatment of schizophrenia |
GB0004415.6 | 2000-02-24 | ||
US75039500A | 2000-12-28 | 2000-12-28 | |
US09/750,395 | 2000-12-28 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2001063293A2 WO2001063293A2 (fr) | 2001-08-30 |
WO2001063293A8 true WO2001063293A8 (fr) | 2001-10-18 |
WO2001063293A3 WO2001063293A3 (fr) | 2002-04-11 |
Family
ID=26243725
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2001/000792 WO2001062785A2 (fr) | 2000-02-24 | 2001-02-23 | Proteines, genes et leur utilisation dans le diagnostic et le traitement de la schizophrenie |
PCT/GB2001/000783 WO2001063293A2 (fr) | 2000-02-24 | 2001-02-23 | Proteines et genes et leur utilisation dans le diagnostic et le traitement de la schizophrenie |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2001/000792 WO2001062785A2 (fr) | 2000-02-24 | 2001-02-23 | Proteines, genes et leur utilisation dans le diagnostic et le traitement de la schizophrenie |
Country Status (3)
Country | Link |
---|---|
EP (2) | EP1259607A2 (fr) |
AU (2) | AU2001237543A1 (fr) |
WO (2) | WO2001062785A2 (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2280030A3 (fr) | 2001-04-10 | 2011-06-15 | Agensys, Inc. | Acides nucléiques et protéines correspondantes utiles dans la détection et le traitement des différents cancers |
JP2003284574A (ja) * | 2001-10-03 | 2003-10-07 | Pfizer Prod Inc | 核酸分子、ポリペプチド、ならびにアルツハイマー病の診断および処置を含むそれらの使用 |
US7052849B2 (en) | 2001-11-23 | 2006-05-30 | Syn X Pharma, Inc. | Protein biopolymer markers predictive of insulin resistance |
US20030100012A1 (en) * | 2001-11-23 | 2003-05-29 | George Jackowski | Plasma protease C1 biopolymer markers predictive of alzheimers disease |
WO2003072543A2 (fr) | 2002-02-21 | 2003-09-04 | Quark Biotech, Inc. | Methodes de prevention ou de traitement d'ischemies ou de lesions cerebrales |
CN1300588C (zh) * | 2005-02-28 | 2007-02-14 | 上海交通大学 | 用于精神分裂症诊断的血浆特异性蛋白获取方法及应用 |
GB0701626D0 (en) | 2007-01-22 | 2007-03-07 | Cambridge Entpr Ltd | Methods and biomarkers for diagnosing and monitoring psychotic disorders |
WO2010079511A2 (fr) * | 2008-12-27 | 2010-07-15 | Pawan Saharan | Nanopeptides dérivés d'un colostrum mammalien pour infections virales et récurrentes à large spectre avec leur procédé d'isolement |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6319687B1 (en) * | 1992-09-24 | 2001-11-20 | The United States Of America As Represented By The Department Of Health And Human Services | Pigment epithelium-derived factor: characterization, genomic organization and sequence of PEDF gene |
US5767252A (en) * | 1996-04-08 | 1998-06-16 | The Johns Hopkins University School Of Medicine | Neuronal cell growth factor, Narp |
WO1998011222A1 (fr) * | 1996-09-13 | 1998-03-19 | The Mount Sinai School Of Medicine Of The City University Of New York | Methodes de selection de composes utilisables pour traiter la schizophrenie |
WO1998040748A1 (fr) * | 1997-03-14 | 1998-09-17 | Neuromark | Diagnostic de troubles neurologiques |
US5939316A (en) * | 1997-03-27 | 1999-08-17 | Millennium Pharmaceuticals, Inc. | Chromosome 18 marker |
AU9379198A (en) * | 1997-09-05 | 1999-03-22 | Acorda Therapeutics, Inc. | Hnk-1 sulfotransferase and methods of use therefor |
IL134968A0 (en) * | 1997-09-17 | 2001-05-20 | Genentech Inc | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
US6248527B1 (en) * | 1998-10-21 | 2001-06-19 | Millennium Pharmaceuticals, Inc. | Method of detecting risk of type II diabetes based on mutations found in carboxypeptidase E |
AU3395900A (en) * | 1999-03-12 | 2000-10-04 | Human Genome Sciences, Inc. | Human lung cancer associated gene sequences and polypeptides |
WO2001025268A1 (fr) * | 1999-10-04 | 2001-04-12 | Schrotz King Petra | Proteines humaines associees a l'attaque |
EP1101820A1 (fr) * | 1999-11-15 | 2001-05-23 | MERCK PATENT GmbH | Pentraxin I et recepteur de la pentraxin, inhibiteurs de ces proteines et compositions pharmaceutiques comprenant ces composés |
-
2001
- 2001-02-23 AU AU2001237543A patent/AU2001237543A1/en not_active Abandoned
- 2001-02-23 EP EP01909957A patent/EP1259607A2/fr not_active Withdrawn
- 2001-02-23 WO PCT/GB2001/000792 patent/WO2001062785A2/fr not_active Application Discontinuation
- 2001-02-23 WO PCT/GB2001/000783 patent/WO2001063293A2/fr not_active Application Discontinuation
- 2001-02-23 EP EP01905991A patent/EP1259818A2/fr not_active Withdrawn
- 2001-02-23 AU AU2001233954A patent/AU2001233954A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1259818A2 (fr) | 2002-11-27 |
AU2001233954A1 (en) | 2001-09-03 |
WO2001063293A3 (fr) | 2002-04-11 |
WO2001063293A2 (fr) | 2001-08-30 |
EP1259607A2 (fr) | 2002-11-27 |
WO2001062785A3 (fr) | 2002-01-31 |
AU2001237543A1 (en) | 2001-09-03 |
WO2001062785A2 (fr) | 2001-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002059604A8 (fr) | Proteines, genes et leur utilisation pour le diagnostic et le traitement de la sclerose en plaques | |
WO2001075454A3 (fr) | Molecules d'acides nucleiques, polypeptides et leurs utilisations pour diagnostic et le traitement de la maladie d'alzheimer notamment | |
WO2002054081A3 (fr) | Proteines, genes et leur utilisation pour le diagnostic et le traitement de la reponse renale | |
WO2003028543A3 (fr) | Molecules d'acide nucleique, polypeptides et utilisations associees comprenant le diagnostic et le traitement de la maladie d'alzheimer | |
WO2002082075A3 (fr) | Procede de depistage de maladies dementielles chroniques, et peptides et reactifs de depistage correspondants | |
CA2421007A1 (fr) | Procede de detection, dans du plasma ou du serum, d'arn associe a des telomerases htr et htert | |
DE60126592D1 (de) | Verfahren, zusammensetzungen und kits zur identifizierung und überwachung von brustkrebs | |
WO2003087831A3 (fr) | Proteines impliquees dans le cancer du sein | |
BRPI0413495A (pt) | reagentes de peptìdeos especìficos para prìons e seus usos | |
DE60137264D1 (de) | Monoklonale antikörper und zelloberflächenantigene zum nachweis und zur behandlung von kleinzelligem lungenkrebs (sclc) | |
WO2005056585A3 (fr) | Protéines s du coronavirus du sars et leurs utilisations | |
WO2001013117A3 (fr) | Proteines et genes destines au diagnostic et au traitement du cancer du sein et leur utilisation | |
WO2002046767A3 (fr) | Molecules d'acide nucleique, polypeptides et utilisations associees, parmi lesquelles diagnostic et traitement de la maladie d'alzheimer | |
WO2001063293A8 (fr) | Proteines et genes et leur utilisation dans le diagnostic et le traitement de la schizophrenie | |
WO2001062784A3 (fr) | Proteines | |
DE60125537D1 (de) | Zusammensetzung zur diagnose und behandlung von herpes simplex virusinfektionen | |
WO2002090974A3 (fr) | Procede pour depister une maladie dementielle chronique evolutive, et peptides et reactifs de depistage associes | |
WO2001063294A3 (fr) | Proteines, genes et leur utilisation dans le diagnostic et le traitement de maladies affectives bipolaires (bad) et de depressions unipolaires | |
EP1283272A3 (fr) | Méthodes et moyens d'évaluation d'une thérapie à base des inhibiteurs de l'enveloppe du VIH | |
WO2001069261A3 (fr) | Proteines, genes et leur utilisation dans le diagnostic et le traitement de la demence vasculaire | |
WO2003048734A3 (fr) | Detection d'arn de metalloproteinase matricielle dans du plasma et du serum | |
HUP0101285A2 (hu) | Eljárások és készítmények a hepatóma diagnosztizálására | |
DE60101305D1 (de) | Dpi-6, ein therapeutischer biomarker in neurologischen krankheiten | |
WO2005049641A3 (fr) | Polypeptides de campylobacter jejuni localises en surface | |
WO2002054080A3 (fr) | Proteines, genes et leur utilisation pour le diagnostic et le traitement de la reponse vasculaire |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
AK | Designated states |
Kind code of ref document: C1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: C1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
CFP | Corrected version of a pamphlet front page | ||
CR1 | Correction of entry in section i |
Free format text: PAT. BUL. 35/2001 UNDER (30) REPLACE "28.02.2000" BY "28.12.2000" |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001905991 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2001905991 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2001905991 Country of ref document: EP |
|
NENP | Non-entry into the national phase in: |
Ref country code: JP |